Picture of Orexo AB logo

ORX Orexo AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Orexo AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-214-184-110-140-353
Depreciation
Non-Cash Items-69.8-72.222.8-25.51,100
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital230.8-85.3-56.113.5
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-229-157-95-32.7828
Capital Expenditures-52.8-23.9-19.2-4.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.1-211220-0.6-19.2
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-52.9-235201-5.3-19.2
Financing Cash Flow Items0.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities251-21.4-70.1-15.5-2.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.2-37238.8-47.7789